Global Human Augmentation in Healthcare Market Growth (Status and Outlook) 2022-2028
- Category: Healthcare
- Published Date: Nov 2022
- Publisher: LP Information
- Pages: 122
The global market for Human Augmentation in Healthcare is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Human Augmentation in Healthcare market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Human Augmentation in Healthcare market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Human Augmentation in Healthcare market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Human Augmentation in Healthcare market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Human Augmentation in Healthcare players cover 20 Knots Plus Ltd (20KTS+), Abbott Laboratories, AbbVie Inc., Abiomed and Asahi Kasei Kuraray Medical Co. Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Human Augmentation in Healthcare market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Human Augmentation in Healthcare market, with both quantitative and qualitative data, to help readers understand how the Human Augmentation in Healthcare market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Human Augmentation in Healthcare market and forecasts the market size by Type (Power Prosthetics, Artificial Organ and Exoskeletons), by Application (General Medical and Military Application.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Power Prosthetics
Artificial Organ
Exoskeletons
Others
Segmentation by application
General Medical
Military Application
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
20 Knots Plus Ltd (20KTS+)
Abbott Laboratories
AbbVie Inc.
Abiomed
Asahi Kasei Kuraray Medical Co. Ltd.
Baxter International
Bionic Power
Boston Scientific Corporation
Cochlear Ltd.
Edwards Lifesciences Corporation
Ekso Bionics Holdings Inc.
ExoAtlet
LivaNova PLC
Lockheed Martin Corporation
Medtronic plc
Orthofix Holdings Inc.
Ossur Corporate
Otto Bock HealthCare GmBH
RB3D
Retina Implant AG
Sarcos Corporation
Sonova Holding AG
Spring Active
SRI International
SynCardia Systems LLC
Zimmer Biomet Holdings
Chapter Introduction
Chapter 1: Scope of Human Augmentation in Healthcare, Research Methodology, etc.
Chapter 2: Executive Summary, global Human Augmentation in Healthcare market size and CAGR, Human Augmentation in Healthcare market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Human Augmentation in Healthcare revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Human Augmentation in Healthcare revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Human Augmentation in Healthcare market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including 20 Knots Plus Ltd (20KTS+), Abbott Laboratories, AbbVie Inc., Abiomed, Asahi Kasei Kuraray Medical Co. Ltd., Baxter International, Bionic Power, Boston Scientific Corporation and Cochlear Ltd., etc.
Chapter 14: Research Findings and Conclusion
The APAC Human Augmentation in Healthcare market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Human Augmentation in Healthcare market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Human Augmentation in Healthcare market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Human Augmentation in Healthcare market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Human Augmentation in Healthcare players cover 20 Knots Plus Ltd (20KTS+), Abbott Laboratories, AbbVie Inc., Abiomed and Asahi Kasei Kuraray Medical Co. Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Human Augmentation in Healthcare market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Human Augmentation in Healthcare market, with both quantitative and qualitative data, to help readers understand how the Human Augmentation in Healthcare market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Human Augmentation in Healthcare market and forecasts the market size by Type (Power Prosthetics, Artificial Organ and Exoskeletons), by Application (General Medical and Military Application.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Power Prosthetics
Artificial Organ
Exoskeletons
Others
Segmentation by application
General Medical
Military Application
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
20 Knots Plus Ltd (20KTS+)
Abbott Laboratories
AbbVie Inc.
Abiomed
Asahi Kasei Kuraray Medical Co. Ltd.
Baxter International
Bionic Power
Boston Scientific Corporation
Cochlear Ltd.
Edwards Lifesciences Corporation
Ekso Bionics Holdings Inc.
ExoAtlet
LivaNova PLC
Lockheed Martin Corporation
Medtronic plc
Orthofix Holdings Inc.
Ossur Corporate
Otto Bock HealthCare GmBH
RB3D
Retina Implant AG
Sarcos Corporation
Sonova Holding AG
Spring Active
SRI International
SynCardia Systems LLC
Zimmer Biomet Holdings
Chapter Introduction
Chapter 1: Scope of Human Augmentation in Healthcare, Research Methodology, etc.
Chapter 2: Executive Summary, global Human Augmentation in Healthcare market size and CAGR, Human Augmentation in Healthcare market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Human Augmentation in Healthcare revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Human Augmentation in Healthcare revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Human Augmentation in Healthcare market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including 20 Knots Plus Ltd (20KTS+), Abbott Laboratories, AbbVie Inc., Abiomed, Asahi Kasei Kuraray Medical Co. Ltd., Baxter International, Bionic Power, Boston Scientific Corporation and Cochlear Ltd., etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Augmentation in Healthcare Market Size 2017-2028
2.1.2 Human Augmentation in Healthcare Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Human Augmentation in Healthcare Segment by Type
2.2.1 Power Prosthetics
2.2.2 Artificial Organ
2.2.3 Exoskeletons
2.2.4 Others
2.3 Human Augmentation in Healthcare Market Size by Type
2.3.1 Human Augmentation in Healthcare Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Human Augmentation in Healthcare Market Size Market Share by Type (2017-2022)
2.4 Human Augmentation in Healthcare Segment by Application
2.4.1 General Medical
2.4.2 Military Application
2.5 Human Augmentation in Healthcare Market Size by Application
2.5.1 Human Augmentation in Healthcare Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Human Augmentation in Healthcare Market Size Market Share by Application (2017-2022)
3 Human Augmentation in Healthcare Market Size by Player
3.1 Human Augmentation in Healthcare Market Size Market Share by Players
3.1.1 Global Human Augmentation in Healthcare Revenue by Players (2020-2022)
3.1.2 Global Human Augmentation in Healthcare Revenue Market Share by Players (2020-2022)
3.2 Global Human Augmentation in Healthcare Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Human Augmentation in Healthcare by Regions
4.1 Human Augmentation in Healthcare Market Size by Regions (2017-2022)
4.2 Americas Human Augmentation in Healthcare Market Size Growth (2017-2022)
4.3 APAC Human Augmentation in Healthcare Market Size Growth (2017-2022)
4.4 Europe Human Augmentation in Healthcare Market Size Growth (2017-2022)
4.5 Middle East & Africa Human Augmentation in Healthcare Market Size Growth (2017-2022)
5 Americas
5.1 Americas Human Augmentation in Healthcare Market Size by Country (2017-2022)
5.2 Americas Human Augmentation in Healthcare Market Size by Type (2017-2022)
5.3 Americas Human Augmentation in Healthcare Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Augmentation in Healthcare Market Size by Region (2017-2022)
6.2 APAC Human Augmentation in Healthcare Market Size by Type (2017-2022)
6.3 APAC Human Augmentation in Healthcare Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Human Augmentation in Healthcare by Country (2017-2022)
7.2 Europe Human Augmentation in Healthcare Market Size by Type (2017-2022)
7.3 Europe Human Augmentation in Healthcare Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Augmentation in Healthcare by Region (2017-2022)
8.2 Middle East & Africa Human Augmentation in Healthcare Market Size by Type (2017-2022)
8.3 Middle East & Africa Human Augmentation in Healthcare Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Human Augmentation in Healthcare Market Forecast
10.1 Global Human Augmentation in Healthcare Forecast by Regions (2023-2028)
10.1.1 Global Human Augmentation in Healthcare Forecast by Regions (2023-2028)
10.1.2 Americas Human Augmentation in Healthcare Forecast
10.1.3 APAC Human Augmentation in Healthcare Forecast
10.1.4 Europe Human Augmentation in Healthcare Forecast
10.1.5 Middle East & Africa Human Augmentation in Healthcare Forecast
10.2 Americas Human Augmentation in Healthcare Forecast by Country (2023-2028)
10.2.1 United States Human Augmentation in Healthcare Market Forecast
10.2.2 Canada Human Augmentation in Healthcare Market Forecast
10.2.3 Mexico Human Augmentation in Healthcare Market Forecast
10.2.4 Brazil Human Augmentation in Healthcare Market Forecast
10.3 APAC Human Augmentation in Healthcare Forecast by Region (2023-2028)
10.3.1 China Human Augmentation in Healthcare Market Forecast
10.3.2 Japan Human Augmentation in Healthcare Market Forecast
10.3.3 Korea Human Augmentation in Healthcare Market Forecast
10.3.4 Southeast Asia Human Augmentation in Healthcare Market Forecast
10.3.5 India Human Augmentation in Healthcare Market Forecast
10.3.6 Australia Human Augmentation in Healthcare Market Forecast
10.4 Europe Human Augmentation in Healthcare Forecast by Country (2023-2028)
10.4.1 Germany Human Augmentation in Healthcare Market Forecast
10.4.2 France Human Augmentation in Healthcare Market Forecast
10.4.3 UK Human Augmentation in Healthcare Market Forecast
10.4.4 Italy Human Augmentation in Healthcare Market Forecast
10.4.5 Russia Human Augmentation in Healthcare Market Forecast
10.5 Middle East & Africa Human Augmentation in Healthcare Forecast by Region (2023-2028)
10.5.1 Egypt Human Augmentation in Healthcare Market Forecast
10.5.2 South Africa Human Augmentation in Healthcare Market Forecast
10.5.3 Israel Human Augmentation in Healthcare Market Forecast
10.5.4 Turkey Human Augmentation in Healthcare Market Forecast
10.5.5 GCC Countries Human Augmentation in Healthcare Market Forecast
10.6 Global Human Augmentation in Healthcare Forecast by Type (2023-2028)
10.7 Global Human Augmentation in Healthcare Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 20 Knots Plus Ltd (20KTS+)
11.1.1 20 Knots Plus Ltd (20KTS+) Company Information
11.1.2 20 Knots Plus Ltd (20KTS+) Human Augmentation in Healthcare Product Offered
11.1.3 20 Knots Plus Ltd (20KTS+) Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 20 Knots Plus Ltd (20KTS+) Main Business Overview
11.1.5 20 Knots Plus Ltd (20KTS+) Latest Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Human Augmentation in Healthcare Product Offered
11.2.3 Abbott Laboratories Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abbott Laboratories Main Business Overview
11.2.5 Abbott Laboratories Latest Developments
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Information
11.3.2 AbbVie Inc. Human Augmentation in Healthcare Product Offered
11.3.3 AbbVie Inc. Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 AbbVie Inc. Main Business Overview
11.3.5 AbbVie Inc. Latest Developments
11.4 Abiomed
11.4.1 Abiomed Company Information
11.4.2 Abiomed Human Augmentation in Healthcare Product Offered
11.4.3 Abiomed Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Abiomed Main Business Overview
11.4.5 Abiomed Latest Developments
11.5 Asahi Kasei Kuraray Medical Co. Ltd.
11.5.1 Asahi Kasei Kuraray Medical Co. Ltd. Company Information
11.5.2 Asahi Kasei Kuraray Medical Co. Ltd. Human Augmentation in Healthcare Product Offered
11.5.3 Asahi Kasei Kuraray Medical Co. Ltd. Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Asahi Kasei Kuraray Medical Co. Ltd. Main Business Overview
11.5.5 Asahi Kasei Kuraray Medical Co. Ltd. Latest Developments
11.6 Baxter International
11.6.1 Baxter International Company Information
11.6.2 Baxter International Human Augmentation in Healthcare Product Offered
11.6.3 Baxter International Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Baxter International Main Business Overview
11.6.5 Baxter International Latest Developments
11.7 Bionic Power
11.7.1 Bionic Power Company Information
11.7.2 Bionic Power Human Augmentation in Healthcare Product Offered
11.7.3 Bionic Power Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bionic Power Main Business Overview
11.7.5 Bionic Power Latest Developments
11.8 Boston Scientific Corporation
11.8.1 Boston Scientific Corporation Company Information
11.8.2 Boston Scientific Corporation Human Augmentation in Healthcare Product Offered
11.8.3 Boston Scientific Corporation Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Boston Scientific Corporation Main Business Overview
11.8.5 Boston Scientific Corporation Latest Developments
11.9 Cochlear Ltd.
11.9.1 Cochlear Ltd. Company Information
11.9.2 Cochlear Ltd. Human Augmentation in Healthcare Product Offered
11.9.3 Cochlear Ltd. Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Cochlear Ltd. Main Business Overview
11.9.5 Cochlear Ltd. Latest Developments
11.10 Edwards Lifesciences Corporation
11.10.1 Edwards Lifesciences Corporation Company Information
11.10.2 Edwards Lifesciences Corporation Human Augmentation in Healthcare Product Offered
11.10.3 Edwards Lifesciences Corporation Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Edwards Lifesciences Corporation Main Business Overview
11.10.5 Edwards Lifesciences Corporation Latest Developments
11.11 Ekso Bionics Holdings Inc.
11.11.1 Ekso Bionics Holdings Inc. Company Information
11.11.2 Ekso Bionics Holdings Inc. Human Augmentation in Healthcare Product Offered
11.11.3 Ekso Bionics Holdings Inc. Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Ekso Bionics Holdings Inc. Main Business Overview
11.11.5 Ekso Bionics Holdings Inc. Latest Developments
11.12 ExoAtlet
11.12.1 ExoAtlet Company Information
11.12.2 ExoAtlet Human Augmentation in Healthcare Product Offered
11.12.3 ExoAtlet Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 ExoAtlet Main Business Overview
11.12.5 ExoAtlet Latest Developments
11.13 LivaNova PLC
11.13.1 LivaNova PLC Company Information
11.13.2 LivaNova PLC Human Augmentation in Healthcare Product Offered
11.13.3 LivaNova PLC Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 LivaNova PLC Main Business Overview
11.13.5 LivaNova PLC Latest Developments
11.14 Lockheed Martin Corporation
11.14.1 Lockheed Martin Corporation Company Information
11.14.2 Lockheed Martin Corporation Human Augmentation in Healthcare Product Offered
11.14.3 Lockheed Martin Corporation Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Lockheed Martin Corporation Main Business Overview
11.14.5 Lockheed Martin Corporation Latest Developments
11.15 Medtronic plc
11.15.1 Medtronic plc Company Information
11.15.2 Medtronic plc Human Augmentation in Healthcare Product Offered
11.15.3 Medtronic plc Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Medtronic plc Main Business Overview
11.15.5 Medtronic plc Latest Developments
11.16 Orthofix Holdings Inc.
11.16.1 Orthofix Holdings Inc. Company Information
11.16.2 Orthofix Holdings Inc. Human Augmentation in Healthcare Product Offered
11.16.3 Orthofix Holdings Inc. Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Orthofix Holdings Inc. Main Business Overview
11.16.5 Orthofix Holdings Inc. Latest Developments
11.17 Ossur Corporate
11.17.1 Ossur Corporate Company Information
11.17.2 Ossur Corporate Human Augmentation in Healthcare Product Offered
11.17.3 Ossur Corporate Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Ossur Corporate Main Business Overview
11.17.5 Ossur Corporate Latest Developments
11.18 Otto Bock HealthCare GmBH
11.18.1 Otto Bock HealthCare GmBH Company Information
11.18.2 Otto Bock HealthCare GmBH Human Augmentation in Healthcare Product Offered
11.18.3 Otto Bock HealthCare GmBH Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Otto Bock HealthCare GmBH Main Business Overview
11.18.5 Otto Bock HealthCare GmBH Latest Developments
11.19 RB3D
11.19.1 RB3D Company Information
11.19.2 RB3D Human Augmentation in Healthcare Product Offered
11.19.3 RB3D Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 RB3D Main Business Overview
11.19.5 RB3D Latest Developments
11.20 Retina Implant AG
11.20.1 Retina Implant AG Company Information
11.20.2 Retina Implant AG Human Augmentation in Healthcare Product Offered
11.20.3 Retina Implant AG Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Retina Implant AG Main Business Overview
11.20.5 Retina Implant AG Latest Developments
11.21 Sarcos Corporation
11.21.1 Sarcos Corporation Company Information
11.21.2 Sarcos Corporation Human Augmentation in Healthcare Product Offered
11.21.3 Sarcos Corporation Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Sarcos Corporation Main Business Overview
11.21.5 Sarcos Corporation Latest Developments
11.22 Sonova Holding AG
11.22.1 Sonova Holding AG Company Information
11.22.2 Sonova Holding AG Human Augmentation in Healthcare Product Offered
11.22.3 Sonova Holding AG Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Sonova Holding AG Main Business Overview
11.22.5 Sonova Holding AG Latest Developments
11.23 Spring Active
11.23.1 Spring Active Company Information
11.23.2 Spring Active Human Augmentation in Healthcare Product Offered
11.23.3 Spring Active Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Spring Active Main Business Overview
11.23.5 Spring Active Latest Developments
11.24 SRI International
11.24.1 SRI International Company Information
11.24.2 SRI International Human Augmentation in Healthcare Product Offered
11.24.3 SRI International Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 SRI International Main Business Overview
11.24.5 SRI International Latest Developments
11.25 SynCardia Systems LLC
11.25.1 SynCardia Systems LLC Company Information
11.25.2 SynCardia Systems LLC Human Augmentation in Healthcare Product Offered
11.25.3 SynCardia Systems LLC Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 SynCardia Systems LLC Main Business Overview
11.25.5 SynCardia Systems LLC Latest Developments
11.26 Zimmer Biomet Holdings
11.26.1 Zimmer Biomet Holdings Company Information
11.26.2 Zimmer Biomet Holdings Human Augmentation in Healthcare Product Offered
11.26.3 Zimmer Biomet Holdings Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Zimmer Biomet Holdings Main Business Overview
11.26.5 Zimmer Biomet Holdings Latest Developments
12 Research Findings and Conclusion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Augmentation in Healthcare Market Size 2017-2028
2.1.2 Human Augmentation in Healthcare Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Human Augmentation in Healthcare Segment by Type
2.2.1 Power Prosthetics
2.2.2 Artificial Organ
2.2.3 Exoskeletons
2.2.4 Others
2.3 Human Augmentation in Healthcare Market Size by Type
2.3.1 Human Augmentation in Healthcare Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Human Augmentation in Healthcare Market Size Market Share by Type (2017-2022)
2.4 Human Augmentation in Healthcare Segment by Application
2.4.1 General Medical
2.4.2 Military Application
2.5 Human Augmentation in Healthcare Market Size by Application
2.5.1 Human Augmentation in Healthcare Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Human Augmentation in Healthcare Market Size Market Share by Application (2017-2022)
3 Human Augmentation in Healthcare Market Size by Player
3.1 Human Augmentation in Healthcare Market Size Market Share by Players
3.1.1 Global Human Augmentation in Healthcare Revenue by Players (2020-2022)
3.1.2 Global Human Augmentation in Healthcare Revenue Market Share by Players (2020-2022)
3.2 Global Human Augmentation in Healthcare Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Human Augmentation in Healthcare by Regions
4.1 Human Augmentation in Healthcare Market Size by Regions (2017-2022)
4.2 Americas Human Augmentation in Healthcare Market Size Growth (2017-2022)
4.3 APAC Human Augmentation in Healthcare Market Size Growth (2017-2022)
4.4 Europe Human Augmentation in Healthcare Market Size Growth (2017-2022)
4.5 Middle East & Africa Human Augmentation in Healthcare Market Size Growth (2017-2022)
5 Americas
5.1 Americas Human Augmentation in Healthcare Market Size by Country (2017-2022)
5.2 Americas Human Augmentation in Healthcare Market Size by Type (2017-2022)
5.3 Americas Human Augmentation in Healthcare Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Augmentation in Healthcare Market Size by Region (2017-2022)
6.2 APAC Human Augmentation in Healthcare Market Size by Type (2017-2022)
6.3 APAC Human Augmentation in Healthcare Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Human Augmentation in Healthcare by Country (2017-2022)
7.2 Europe Human Augmentation in Healthcare Market Size by Type (2017-2022)
7.3 Europe Human Augmentation in Healthcare Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Augmentation in Healthcare by Region (2017-2022)
8.2 Middle East & Africa Human Augmentation in Healthcare Market Size by Type (2017-2022)
8.3 Middle East & Africa Human Augmentation in Healthcare Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Human Augmentation in Healthcare Market Forecast
10.1 Global Human Augmentation in Healthcare Forecast by Regions (2023-2028)
10.1.1 Global Human Augmentation in Healthcare Forecast by Regions (2023-2028)
10.1.2 Americas Human Augmentation in Healthcare Forecast
10.1.3 APAC Human Augmentation in Healthcare Forecast
10.1.4 Europe Human Augmentation in Healthcare Forecast
10.1.5 Middle East & Africa Human Augmentation in Healthcare Forecast
10.2 Americas Human Augmentation in Healthcare Forecast by Country (2023-2028)
10.2.1 United States Human Augmentation in Healthcare Market Forecast
10.2.2 Canada Human Augmentation in Healthcare Market Forecast
10.2.3 Mexico Human Augmentation in Healthcare Market Forecast
10.2.4 Brazil Human Augmentation in Healthcare Market Forecast
10.3 APAC Human Augmentation in Healthcare Forecast by Region (2023-2028)
10.3.1 China Human Augmentation in Healthcare Market Forecast
10.3.2 Japan Human Augmentation in Healthcare Market Forecast
10.3.3 Korea Human Augmentation in Healthcare Market Forecast
10.3.4 Southeast Asia Human Augmentation in Healthcare Market Forecast
10.3.5 India Human Augmentation in Healthcare Market Forecast
10.3.6 Australia Human Augmentation in Healthcare Market Forecast
10.4 Europe Human Augmentation in Healthcare Forecast by Country (2023-2028)
10.4.1 Germany Human Augmentation in Healthcare Market Forecast
10.4.2 France Human Augmentation in Healthcare Market Forecast
10.4.3 UK Human Augmentation in Healthcare Market Forecast
10.4.4 Italy Human Augmentation in Healthcare Market Forecast
10.4.5 Russia Human Augmentation in Healthcare Market Forecast
10.5 Middle East & Africa Human Augmentation in Healthcare Forecast by Region (2023-2028)
10.5.1 Egypt Human Augmentation in Healthcare Market Forecast
10.5.2 South Africa Human Augmentation in Healthcare Market Forecast
10.5.3 Israel Human Augmentation in Healthcare Market Forecast
10.5.4 Turkey Human Augmentation in Healthcare Market Forecast
10.5.5 GCC Countries Human Augmentation in Healthcare Market Forecast
10.6 Global Human Augmentation in Healthcare Forecast by Type (2023-2028)
10.7 Global Human Augmentation in Healthcare Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 20 Knots Plus Ltd (20KTS+)
11.1.1 20 Knots Plus Ltd (20KTS+) Company Information
11.1.2 20 Knots Plus Ltd (20KTS+) Human Augmentation in Healthcare Product Offered
11.1.3 20 Knots Plus Ltd (20KTS+) Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 20 Knots Plus Ltd (20KTS+) Main Business Overview
11.1.5 20 Knots Plus Ltd (20KTS+) Latest Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Human Augmentation in Healthcare Product Offered
11.2.3 Abbott Laboratories Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abbott Laboratories Main Business Overview
11.2.5 Abbott Laboratories Latest Developments
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Information
11.3.2 AbbVie Inc. Human Augmentation in Healthcare Product Offered
11.3.3 AbbVie Inc. Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 AbbVie Inc. Main Business Overview
11.3.5 AbbVie Inc. Latest Developments
11.4 Abiomed
11.4.1 Abiomed Company Information
11.4.2 Abiomed Human Augmentation in Healthcare Product Offered
11.4.3 Abiomed Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Abiomed Main Business Overview
11.4.5 Abiomed Latest Developments
11.5 Asahi Kasei Kuraray Medical Co. Ltd.
11.5.1 Asahi Kasei Kuraray Medical Co. Ltd. Company Information
11.5.2 Asahi Kasei Kuraray Medical Co. Ltd. Human Augmentation in Healthcare Product Offered
11.5.3 Asahi Kasei Kuraray Medical Co. Ltd. Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Asahi Kasei Kuraray Medical Co. Ltd. Main Business Overview
11.5.5 Asahi Kasei Kuraray Medical Co. Ltd. Latest Developments
11.6 Baxter International
11.6.1 Baxter International Company Information
11.6.2 Baxter International Human Augmentation in Healthcare Product Offered
11.6.3 Baxter International Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Baxter International Main Business Overview
11.6.5 Baxter International Latest Developments
11.7 Bionic Power
11.7.1 Bionic Power Company Information
11.7.2 Bionic Power Human Augmentation in Healthcare Product Offered
11.7.3 Bionic Power Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bionic Power Main Business Overview
11.7.5 Bionic Power Latest Developments
11.8 Boston Scientific Corporation
11.8.1 Boston Scientific Corporation Company Information
11.8.2 Boston Scientific Corporation Human Augmentation in Healthcare Product Offered
11.8.3 Boston Scientific Corporation Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Boston Scientific Corporation Main Business Overview
11.8.5 Boston Scientific Corporation Latest Developments
11.9 Cochlear Ltd.
11.9.1 Cochlear Ltd. Company Information
11.9.2 Cochlear Ltd. Human Augmentation in Healthcare Product Offered
11.9.3 Cochlear Ltd. Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Cochlear Ltd. Main Business Overview
11.9.5 Cochlear Ltd. Latest Developments
11.10 Edwards Lifesciences Corporation
11.10.1 Edwards Lifesciences Corporation Company Information
11.10.2 Edwards Lifesciences Corporation Human Augmentation in Healthcare Product Offered
11.10.3 Edwards Lifesciences Corporation Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Edwards Lifesciences Corporation Main Business Overview
11.10.5 Edwards Lifesciences Corporation Latest Developments
11.11 Ekso Bionics Holdings Inc.
11.11.1 Ekso Bionics Holdings Inc. Company Information
11.11.2 Ekso Bionics Holdings Inc. Human Augmentation in Healthcare Product Offered
11.11.3 Ekso Bionics Holdings Inc. Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Ekso Bionics Holdings Inc. Main Business Overview
11.11.5 Ekso Bionics Holdings Inc. Latest Developments
11.12 ExoAtlet
11.12.1 ExoAtlet Company Information
11.12.2 ExoAtlet Human Augmentation in Healthcare Product Offered
11.12.3 ExoAtlet Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 ExoAtlet Main Business Overview
11.12.5 ExoAtlet Latest Developments
11.13 LivaNova PLC
11.13.1 LivaNova PLC Company Information
11.13.2 LivaNova PLC Human Augmentation in Healthcare Product Offered
11.13.3 LivaNova PLC Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 LivaNova PLC Main Business Overview
11.13.5 LivaNova PLC Latest Developments
11.14 Lockheed Martin Corporation
11.14.1 Lockheed Martin Corporation Company Information
11.14.2 Lockheed Martin Corporation Human Augmentation in Healthcare Product Offered
11.14.3 Lockheed Martin Corporation Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Lockheed Martin Corporation Main Business Overview
11.14.5 Lockheed Martin Corporation Latest Developments
11.15 Medtronic plc
11.15.1 Medtronic plc Company Information
11.15.2 Medtronic plc Human Augmentation in Healthcare Product Offered
11.15.3 Medtronic plc Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Medtronic plc Main Business Overview
11.15.5 Medtronic plc Latest Developments
11.16 Orthofix Holdings Inc.
11.16.1 Orthofix Holdings Inc. Company Information
11.16.2 Orthofix Holdings Inc. Human Augmentation in Healthcare Product Offered
11.16.3 Orthofix Holdings Inc. Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Orthofix Holdings Inc. Main Business Overview
11.16.5 Orthofix Holdings Inc. Latest Developments
11.17 Ossur Corporate
11.17.1 Ossur Corporate Company Information
11.17.2 Ossur Corporate Human Augmentation in Healthcare Product Offered
11.17.3 Ossur Corporate Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Ossur Corporate Main Business Overview
11.17.5 Ossur Corporate Latest Developments
11.18 Otto Bock HealthCare GmBH
11.18.1 Otto Bock HealthCare GmBH Company Information
11.18.2 Otto Bock HealthCare GmBH Human Augmentation in Healthcare Product Offered
11.18.3 Otto Bock HealthCare GmBH Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Otto Bock HealthCare GmBH Main Business Overview
11.18.5 Otto Bock HealthCare GmBH Latest Developments
11.19 RB3D
11.19.1 RB3D Company Information
11.19.2 RB3D Human Augmentation in Healthcare Product Offered
11.19.3 RB3D Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 RB3D Main Business Overview
11.19.5 RB3D Latest Developments
11.20 Retina Implant AG
11.20.1 Retina Implant AG Company Information
11.20.2 Retina Implant AG Human Augmentation in Healthcare Product Offered
11.20.3 Retina Implant AG Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Retina Implant AG Main Business Overview
11.20.5 Retina Implant AG Latest Developments
11.21 Sarcos Corporation
11.21.1 Sarcos Corporation Company Information
11.21.2 Sarcos Corporation Human Augmentation in Healthcare Product Offered
11.21.3 Sarcos Corporation Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Sarcos Corporation Main Business Overview
11.21.5 Sarcos Corporation Latest Developments
11.22 Sonova Holding AG
11.22.1 Sonova Holding AG Company Information
11.22.2 Sonova Holding AG Human Augmentation in Healthcare Product Offered
11.22.3 Sonova Holding AG Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Sonova Holding AG Main Business Overview
11.22.5 Sonova Holding AG Latest Developments
11.23 Spring Active
11.23.1 Spring Active Company Information
11.23.2 Spring Active Human Augmentation in Healthcare Product Offered
11.23.3 Spring Active Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Spring Active Main Business Overview
11.23.5 Spring Active Latest Developments
11.24 SRI International
11.24.1 SRI International Company Information
11.24.2 SRI International Human Augmentation in Healthcare Product Offered
11.24.3 SRI International Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 SRI International Main Business Overview
11.24.5 SRI International Latest Developments
11.25 SynCardia Systems LLC
11.25.1 SynCardia Systems LLC Company Information
11.25.2 SynCardia Systems LLC Human Augmentation in Healthcare Product Offered
11.25.3 SynCardia Systems LLC Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 SynCardia Systems LLC Main Business Overview
11.25.5 SynCardia Systems LLC Latest Developments
11.26 Zimmer Biomet Holdings
11.26.1 Zimmer Biomet Holdings Company Information
11.26.2 Zimmer Biomet Holdings Human Augmentation in Healthcare Product Offered
11.26.3 Zimmer Biomet Holdings Human Augmentation in Healthcare Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Zimmer Biomet Holdings Main Business Overview
11.26.5 Zimmer Biomet Holdings Latest Developments
12 Research Findings and Conclusion
no record found